Interleukin-2 (Aldesleukin)
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for Interleukin-2 (Aldesleukin), covering 2012-09-24 to 2018-07-05. Get the full timeline:
Most recent: Clinical Trial Update: Ultra-Low Dose IL-2 Therapy as GVHD Prophylaxis in Haploidentical Allogeneic Stem Cell Transplantation [Phase 1]